594 related articles for article (PubMed ID: 27564664)
1. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
McCarthy C; Reeves EP; McElvaney NG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
[TBL] [Abstract][Full Text] [Related]
2. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
3. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils.
Lee J; Lu Y; Oshins R; West J; Moneypenny CG; Han K; Brantly ML
Front Immunol; 2020; 11():574410. PubMed ID: 33329539
[TBL] [Abstract][Full Text] [Related]
4. Alpha-1 Antitrypsin Deficiency Today: New Insights in the Immunological Pathways.
Baraldo S; Balestro E; Bazzan E; Tiné ME; Biondini D; Turato G; Cosio MG; Saetta M
Respiration; 2016; 91(5):380-5. PubMed ID: 27164860
[TBL] [Abstract][Full Text] [Related]
5. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.
Hurley K; Reeves EP; Carroll TP; McElvaney NG
Expert Rev Respir Med; 2016 Feb; 10(2):207-22. PubMed ID: 26634397
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
[No Abstract] [Full Text] [Related]
10. Small airways disease in patients with alpha-1 antitrypsin deficiency.
Toumpanakis D; Usmani OS
Respir Med; 2023 May; 211():107222. PubMed ID: 36965591
[TBL] [Abstract][Full Text] [Related]
11. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency.
Belchamber KBR; Walker EM; Stockley RA; Sapey E
Int J Chron Obstruct Pulmon Dis; 2020; 15():3183-3192. PubMed ID: 33311976
[TBL] [Abstract][Full Text] [Related]
12. Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update.
Blanco I; Lipsker D; Lara B; Janciauskiene S
Br J Dermatol; 2016 Apr; 174(4):753-62. PubMed ID: 26595240
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of Alpha-1 Antitrypsin Lung Disease.
Kalfopoulos M; Wetmore K; ElMallah MK
Methods Mol Biol; 2017; 1639():9-19. PubMed ID: 28752442
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
Jonigk D; Al-Omari M; Maegel L; Müller M; Izykowski N; Hong J; Hong K; Kim SH; Dorsch M; Mahadeva R; Laenger F; Kreipe H; Braun A; Shahaf G; Lewis EC; Welte T; Dinarello CA; Janciauskiene S
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15007-12. PubMed ID: 23975926
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice.
Ostermann L; Maus R; Stolper J; Schütte L; Katsarou K; Tumpara S; Pich A; Mueller C; Janciauskiene S; Welte T; Maus UA
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554955
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary manifestations of alpha 1 antitrypsin deficiency.
Mulkareddy V; Roman J
Am J Med Sci; 2024 Jul; 368(1):1-8. PubMed ID: 38599244
[TBL] [Abstract][Full Text] [Related]
19. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches.
Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1 antitrypsin deficiency panniculitis: clinical and pathologic characteristics of 10 cases.
Johnson EF; Tolkachjov SN; Gibson LE
Int J Dermatol; 2018 Aug; 57(8):952-958. PubMed ID: 29707779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
